“Imvax’s story began with a physician’s dedicated pursuit of new hope for patients with a deadly cancer, GBM.”
NEWS November 2023
Our friends at End Brain Cancer are helping to recruit for a GBM clinical trial. A clinical trial can be the best hope for someone with glioblastoma.
“Informed by decades of research, Imvax’s platform elegantly turns the complexity of a solid tumor against itself by capturing its complete antigenic signature and converting it into a highly immunostimulatory ‘training program’. This is designed to deliver both innate and adaptive immune stimulation to overcome the challenges of the remaining solid tumors’ cells.
Imvax’s Goldspire™ platform is a personalized, whole tumor-derived, cell-based autologous immunotherapy that delivers a full tumor antigen payload to patients by combining patient-derived tumor cells and an antisense oligodeoxynucleotide (IMV-001) against insulin-like growth factor type 1 receptor (IGF-1R). The Imvax platform is designed to be incorporated into the standard of care for GBM.”
LATEST NEWS.
OurBrainBank at SNO Annual Meeting 2024
This week, we presented preliminary results of our ambitious survey of 500+ people affected by GBM at the Society for Neuro-Oncology annual conference.
OurBrainBank benefit event in Connecticut Nov. 22, 2024
Please join us on November 22nd for a festive evening of fun, live music, great food and drinks — all to benefit OurBrainBank.
OurBrainBank at AONN+ Annual Meeting 2024
OurBrainBank is at the AONN+ (Academy of Oncology Nurse & Patient Navigators) annual conference in Las Vegas. Stop by our booth and poster to meet Executive Director Kelli Duprey and learn about our survey of disparities in GBM treatment across the USA.
MyTumorID — learn about vital tumor testing
Every brain tumor experience is unique, and every patient deserves a better chance at survival, a better chance at an adequate quality of life, and the best information available to make decisions for their treatment.
LATEST NEWS.
OurBrainBank at SNO Annual Meeting 2024
This week, we presented preliminary results of our ambitious survey of 500+ people affected by GBM at the Society for Neuro-Oncology annual conference.
OurBrainBank benefit event in Connecticut Nov. 22, 2024
Please join us on November 22nd for a festive evening of fun, live music, great food and drinks — all to benefit OurBrainBank.
OurBrainBank at AONN+ Annual Meeting 2024
OurBrainBank is at the AONN+ (Academy of Oncology Nurse & Patient Navigators) annual conference in Las Vegas. Stop by our booth and poster to meet Executive Director Kelli Duprey and learn about our survey of disparities in GBM treatment across the USA.
MyTumorID — learn about vital tumor testing
Every brain tumor experience is unique, and every patient deserves a better chance at survival, a better chance at an adequate quality of life, and the best information available to make decisions for their treatment.